- active not recruitingPHASE1, PHASE2
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
This study is testing a new drug called neratinib for children and young adults with cancer that has come back or not responded to other treatments. The main goals are to find a safe dose and understand its effects on the cancer and patients.
United States · Canada - active not recruitingNA
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)
This study looks at DNA and immune system features in childhood, teenage, and young adult cancers like neuroblastoma and leukaemia. We aim to better understand these high-risk cancers from diagnosis through treatment to find new ways to help. Participants give blood, bone marrow, or spinal fluid samples.
France